<i>DHX37</i> and <i>NR5A1</i> Variants Identified in Patients with 46,XY Partial Gonadal Dysgenesis
Felipe Rodrigues de Oliveira,
Taís Nitsch Mazzola,
Maricilda Palandi de Mello,
Ana Paula Francese-Santos,
Sofia Helena V. de Lemos-Marini,
Andrea Trevas Maciel-Guerra,
Olaf Hiort,
Ralf Werner,
Gil Guerra-Junior,
Helena Fabbri-Scallet
Affiliations
Felipe Rodrigues de Oliveira
Center for Molecular Biology and Genetic Engineering (CBMEG), State University of Campinas (UNICAMP), Campinas 13083-875, Brazil
Taís Nitsch Mazzola
Center for Investigation in Paediatric, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, Brazil
Maricilda Palandi de Mello
Center for Molecular Biology and Genetic Engineering (CBMEG), State University of Campinas (UNICAMP), Campinas 13083-875, Brazil
Ana Paula Francese-Santos
Department of Translational Medicine, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, Brazil
Sofia Helena V. de Lemos-Marini
Department of Pediatrics, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, Brazil
Andrea Trevas Maciel-Guerra
Interdisciplinary Group for the Study of Sex Determination and Differentiation (GIEDDS), State University of Campinas (UNICAMP), Campinas 13083-887, Brazil
Olaf Hiort
Division of Paediatric Endocrinology and Diabetes, Department of Paediatric and Adolescent Medicine, University of Lübeck, 23562 Lübeck, Germany
Ralf Werner
Division of Paediatric Endocrinology and Diabetes, Department of Paediatric and Adolescent Medicine, University of Lübeck, 23562 Lübeck, Germany
Gil Guerra-Junior
Interdisciplinary Group for the Study of Sex Determination and Differentiation (GIEDDS), State University of Campinas (UNICAMP), Campinas 13083-887, Brazil
Helena Fabbri-Scallet
Center for Molecular Biology and Genetic Engineering (CBMEG), State University of Campinas (UNICAMP), Campinas 13083-875, Brazil
The group of disorders known as 46,XY gonadal dysgenesis (GD) is characterized by anomalies in testis determination, including complete and partial GD (PGD) and testicular regression syndrome (TRS). Several genes are known to be involved in sex development pathways, however approximately 50% of all cases remain elusive. Recent studies have identified variants in DHX37, a gene encoding a putative RNA helicase essential in ribosome biogenesis and previously associated with neurodevelopmental disorders, as a cause of PGD and TRS. To investigate the potential role of DHX37 in disorders of sexual development (DSD), 25 individuals with 46,XY DSD were analyzed and putative pathogenic variants were found in four of them. WES analyses were performed on these patients. In DHX37, the variant p.(Arg308Gln), recurrent associated with DSD, was identified in one patient; the p.(Leu467Val), predicted to be deleterious, was found together with an NR5A1 loss-of-function variant in patient 2; and, the p.(Val999Met) was identified in two unrelated patients, one of whom (patient 3) also carried a pathogenic NR5A1 variant. For both patients carrying DHX37 and NR5A1 pathogenic variants, a digenic inheritance is suggested. Our findings support the importance of DHX37 variants as a cause of disorders of sex development, implying a role in testis development.